Search for reporting guidelines

Most recently added records are displayed first.

1
• Supporting best practice in reflexive thematic analysis reporting in Palliative Medicine: A review of published research and introduction to the Reflexive Thematic Analysis Reporting Guidelines (RTARG)
  
2
• TRIPLE C reporting principles for case study evaluations of the role of context in complex interventions
  
3
• Guideline for reporting systematic reviews of outcome measurement instruments (OMIs) : PRISMA-COSMIN for OMIs 2024
  
4
• Consolidated Health Economic Evaluation Reporting Standards for Interventions that use Artificial Intelligence (CHEERS-AI)
  
5
• The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV) : Development and Statement
  
6
• The Reporting Recommendations Intended for Pharmaceutical Risk Minimization Evaluation Studies: Standards for Reporting of Implementation Studies Extension (RIMES-SE)
  
7
• Consensus reporting guidelines to address gaps in descriptions of ultra-rare genetic conditions
  
8
• Biofield therapies: Guidelines for reporting clinical trials
  
9
• The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report
  
10
• REPORT-SCS : minimum reporting standards for spinal cord stimulation studies in spinal cord injury
  
11
• CARE-radiology statement explanation and elaboration: reporting guideline for radiological case reports
  
12
• Trial Forge Guidance 4: a guideline for reporting the results of randomised Studies Within A Trial (SWATs)
  
13
• The RETRIEVE Checklist for Studies Reporting the Elicitation of Stated Preferences for Child Health -Related Quality of Life
  
14
• We don’t know what you did last summer. On the importance of transparent reporting of reaction time data pre-processing
  
15
• Introducing So NHR-Reporting guidelines for Social Networks In Health Research
  
16
• Reporting standard for describing first responder systems, smartphone alerting systems, and AED networks
  
17
• The reporting checklist for Chinese patent medicine guidelines: RIGHT for CPM
  
18
• The SHARE : SHam Acupuncture REporting guidelines and a checklist in clinical trials
  
19
• REPCAN : Guideline for REporting Population-based CANcer Registry Data
  
20
• The Test Adaptation Reporting Standards (TARES) : reporting test adaptations
  
21
• ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi
  
22
• Consolidated Reporting Guidelines for Prognostic and Diagnostic Machine Learning Modeling Studies: Development and Validation
  
23
• Development of the Reporting Infographics and Visual Abstracts of Comparative studies (RIVA-C) checklist and guide
  
24
• Preliminary guideline for reporting bibliometric reviews of the biomedical literature (BIBLIO) : a minimum requirements
  
25
• Appropriate design and reporting of superiority, equivalence and non-inferiority clinical trials incorporating a benefit-risk assessment: the BRAINS study including expert workshop
  
26
• Preferred Reporting Items for Resistance Exercise Studies (PRIRES) : A Checklist Developed Using an Umbrella Review of Systematic Reviews
  
27
• ENLIGHT : A consensus checklist for reporting laboratory-based studies on the non-visual effects of light in humans
  
28
• Consensus Statement for Protocols of Factorial Randomized Trials: Extension of the SPIRIT 2013 Statement
  
29
• Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement
  
30
• Adjusting for Treatment Switching in Oncology Trials: A Systematic Review and Recommendations for Reporting
  
31
• Modeling Infectious Diseases in Healthcare Network (MInD-Healthcare) Framework for Describing and Reporting Multidrug-resistant Organism and Healthcare -Associated Infections Agent-based Modeling Methods
  
32
• LEVEL (Logical Explanations & Visualizations of Estimates in Linear mixed models): recommendations for reporting multilevel data and analyses
  
33
• Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting
  
34
• Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure
  
35
• Commentary: minimum reporting standards should be expected for preclinical radiobiology irradiators and dosimetry in the published literature
  
36
• Best practice guidelines for citizen science in mental health research: systematic review and evidence synthesis
  
37
• Evaluating the quality of studies reporting on clinical applications of stromal vascular fraction: A systematic review and proposed reporting guidelines (CLINIC-STRA-SVF)
  
38
• Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance
  
39
• Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance
  
40
• ESMO Guidance for Reporting Oncology real -World evidence (GROW)
  
41
• A systematic review and cluster analysis approach of 103 studies of high-intensity interval training on cardiorespiratory fitness
  
42
• Generate Analysis -Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies
  
43
• Developing Consensus -Based Guidelines for Case Reporting in Aesthetic Medicine: Enhancing Transparency and Standardization
  
44
• MINIMAR (MINimum Information for Medical AI Reporting): Developing reporting standards for artificial intelligence in health care
  
45
• Presenting artificial intelligence, deep learning, and machine learning studies to clinicians and healthcare stakeholders: an introductory reference with a guideline and a Clinical AI Research (CAIR) checklist proposal
  
46
• Data Processing Strategies to Determine Maximum Oxygen Uptake: A Systematic Scoping Review and Experimental Comparison with Guidelines for Reporting
  
47
• Improving the Rigor of Mechanistic Behavioral Science: The Introduction of the Checklist for Investigating Mechanisms in Behavior -Change Research (CLIMBR)
  
48
• An analysis of reporting practices in the top 100 cited health and medicine-related bibliometric studies from 2019 to 2021 based on a proposed guidelines
  
49
• Improving the Reporting of Primary Care Research: Consensus Reporting Items for Studies in Primary Care-the CRISP Statement
  
50
• Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use
  
51
• Community-developed checklists for publishing images and image analyses
  
52
• Systematic Development of Standards for Mixed Methods Reporting in Rehabilitation Health Sciences Research
  
53
• Minimal reporting guideline for research involving eye tracking (2023 edition)
  
54
• CHEERS Value of Information (CHEERS-VOI) Reporting Standards – Explanation and Elaboration
  
55
• Initial Standardized Framework for Reporting Social Media Analytics in Emergency Care Research
  
56
• The adapted Autobiographical interview: A systematic review and proposal for conduct and reporting
  
57
• Paediatric Ureteroscopy (P-URS) reporting checklist: a new tool to aid studies report the essential items on paediatric ureteroscopy for stone disease
  
58
• Adult Ureteroscopy (A-URS) Checklist: A New Tool To Standardise Reporting in Endourology
  
59
• Recommendations for the development, implementation, and reporting of control interventions in efficacy and mechanistic trials of physical, psychological, and self-management therapies: the Co PPS Statement
  
60
• Reporting Eye-tracking Studies In DEntistry (RESIDE) checklist
  
61
• AdVi SHE : A Validation -Assessment Tool of Health -Economic Models for Decision Makers and Model Users
  
62
• i CHECK-DH : Guidelines and Checklist for the Reporting on Digital Health Implementations
  
63
• New reporting items and recommendations for randomized trials impacted by COVID- 19 and force majeure events: a targeted approach
  
64
• Development, explanation, and presentation of the Physical Literacy Interventions Reporting Template (PLIRT)
  
65
• Reporting guidelines for allergy and immunology survey research
  
66
• CheckList for EvaluAtion of Radiomics research (CLEAR) : a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSo MII
  
67
• Transparent reporting of multivariable prediction models for individual prognosis or diagnosis: checklist for systematic reviews and meta-analyses (TRIPOD-SRMA)
  
68
• Preferred Reporting Items for Complex Sample Survey Analysis (PRICSSA)
  
69
• Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations
  
70
• CORE-CERT Items as a Minimal Requirement for Replicability of Exercise Interventions: Results From Application to Exercise Studies for Breast Cancer Patients
  
71
• Recommendations for Reporting Machine Learning Analyses in Clinical Research
  
72
• ACURATE : A guide for reporting sham controls in trials using acupuncture
  
73
• Checklist for Artificial Intelligence in Medical Imaging (CLAIM) : 2024 Update
  
74
• STandards for Reporting Interventions in Clinical Trials Of Tuina/Massage (STRICTOTM) : Extending the CONSORT statement
  
75
• Transparent reporting of multivariable prediction models developed or validated using clustered data: TRIPOD-Cluster checklist
  
76
• The SUPER reporting guideline suggested for reporting of surgical technique
  
77
• Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension
  
78
• Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension
  
79
• PROBE 2023 guidelines for reporting observational studies in Endodontics: A consensus-based development study
  
80
• CONFERD-HP : recommendations for reporting COmpeteNcy FramEwoRk Development in health professions
  
81
• Development of the ASSESS tool: a comprehenSive tool to Support rEporting and critical appraiSal of qualitative, quantitative, and mixed methods implementation reSearch outcomes
  
82
• Guiding document analyses in health professions education research
  
83
• Evidence-based statistical analysis and methods in biomedical research (SAMBR) checklists according to design features
  
84
• Social Accountability Reporting for Research (SAR 4Research): checklist to strengthen reporting on studies on social accountability in the literature
  
85
• How to Report Data on Bilateral Procedures and Other Issues with Clustered Data: The CLUDA Reporting Guidelines
  
86
• Best practice guidance and reporting items for the development of scoping review protocols
  
87
• Establishing reporting standards for participant characteristics in post-stroke aphasia research: An international e -Delphi exercise and consensus meeting
  
88
• STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting
  
89
• Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research -The ConPhy MP-Guidelines
  
90
• Advising on Preferred Reporting Items for patient-reported outcome instrument development: the PRIPROID
  
91
• Recommendations for reporting the results of studies of instrument and scale development and testing
  
92
• Methodical approaches to determine the rate of radial muscle displacement using tensiomyography: A scoping review and new reporting guideline
  
93
• Methods for developing and reporting living evidence synthesis
  
94
• Bayesian Analysis Reporting Guidelines
  
95
• Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement
  
96
• The Do CTRINE Guidelines: Defined Criteria To Report INnovations in Education
  
97
• Development of guidelines to reduce, handle and report missing data in palliative care trials: A multi-stakeholder modified nominal group technique
  
98
• The RIPI-f (Reporting Integrity of Psychological Interventions delivered face-to-face) checklist was developed to guide reporting of treatment integrity in face-to-face psychological interventions
  
99
• The Intraoperative Complications Assessment and Reporting with Universal Standards (ICARUS) Global Surgical Collaboration Project: Development of Criteria for Reporting Adverse Events During Surgical Procedures and Evaluating Their Impact on the Postoperative Course
  
100
• CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research
  
101
• A Reporting Tool for Adapted Guidelines in Health Care: The RIGHT-Ad@pt Checklist
  
102
• Development of a reporting guideline for systematic reviews of animal experiments in the field of traditional Chinese medicine
  
103
• TIDieR-telehealth : precision in reporting of telehealth interventions used in clinical trials – unique considerations for the Template for the Intervention Description and Replication (TIDieR) checklist
  
104
• Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS
  
105
• Murine models of radiation cardiotoxicity: a systematic review and recommendations for future studies
  
106
• Systematic Review and Meta -Analysis of Outcomes After Operative Treatment of Aberrant Subclavian Artery Pathologies and Suggested Reporting Items
  
107
• Reporting standards for psychological network analyses in cross-sectional data
  
108
• Reporting ChAracteristics of cadaver training and sUrgical studies: The CACTUS guidelines
  
109
• EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology
  
110
• Methods and Applications of Social Media Monitoring of Mental Health During Disasters: Scoping Review
  
111
• Position Statement on Exercise Dosage in Rheumatic and Musculoskeletal Diseases: The Role of the IMPACT-RMD Toolkit
  
112
• A checklist for assessing the methodological quality of concurrent t ES-fMRI studies (ContES checklist): a consensus study and statement
  
113
• Application of Mixed Methods in Health Services Management Research: A Systematic Review
  
114
• Methodological standards for conducting and reporting meta-analyses: Ensuring the replicability of meta-analyses of pharmacist-led medication review
  
115
• A scoping review of the use of ethnographic approaches in implementation research and recommendations for reporting
  
116
• The Chest Wall Injury Society Recommendations for Reporting Studies of Surgical Stabilization of Rib Fractures
  
117
• How to Report Light Exposure in Human Chronobiology and Sleep Research Experiments
  
118
• Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI
  
119
• Use of actigraphy for assessment in pediatric sleep research
  
120
• EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology
  
121
• International Consensus Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020)
  
122
• Refining the CRiSPHe (checklist for reporting research using a simulated patient methodology in Health): a Delphi study
  
123
• Conceptual Ambiguity Surrounding Gamification and Serious Games in Health Care: Literature Review and Development of Game -Based Intervention Reporting Guidelines (GAMING)
  
124
• Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines
  
125
• Six practical recommendations for improved implementation outcomes reporting
  
126
• Recommendations and publication guidelines for studies using frequency domain and time-frequency domain analyses of neural time series
  
127
• EVIDENCE Publication Checklist for Studies Evaluating Connected Sensor Technologies: Explanation and Elaboration
  
128
• An extension of the RIGHT statement for introductions and interpretations of clinical practice guidelines: RIGHT for INT
  
129
• Rasch Reporting Guideline for Rehabilitation Research (RULER) : The RULER Statement
  
130
• Using qualitative research to develop an elaboration of the TIDieR checklist for interventions to enhance vaccination communication: short report
  
131
• Preliminary Minimum Reporting Requirements for In -Vivo Neural Interface Research: I. Implantable Neural Interfaces
  
132
• Standardized Reporting of Machine Learning Applications in Urology: The STREAM-URO Framework
  
133
• Guidance for publishing qualitative research in informatics
  
134
• Guidelines for reporting on animal fecal transplantation (GRAFT) studies: recommendations from a systematic review of murine transplantation protocols
  
135
• A Scoping Review of Four Decades of Outcomes in Nonsurgical Root Canal Treatment, Nonsurgical Retreatment, and Apexification Studies: Part 3 -A Proposed Framework for Standardized Data Collection and Reporting of Endodontic Outcome Studies
  
136
• Health -Economic Analyses of Diagnostics: Guidance on Design and Reporting
  
137
• Reporting guidelines for human microbiome research: the STORMS checklist
  
138
• Smartphone -Delivered Ecological Momentary Interventions Based on Ecological Momentary Assessments to Promote Health Behaviors: Systematic Review and Adapted Checklist for Reporting Ecological Momentary Assessment and Intervention Studies
  
139
• A Systematic Review of Methods and Procedures Used in Ecological Momentary Assessments of Diet and Physical Activity Research in Youth: An Adapted STROBE Checklist for Reporting EMA Studies (CREMAS)
  
140
• Reporting Data on Auditory Brainstem Responses (ABR) in Rats: Recommendations Based on Review of Experimental Protocols and Literature
  
141
• Heterogeneity in the Identification of Potential Drug -Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations
  
142
• Development of the CLARIFY (CheckList stAndardising the Reporting of Interventions For Yoga) guidelines: a Delphi study
  
143
• Early phase clinical trials extension to guidelines for the content of statistical analysis plans
  
144
• PRESENT 2020: Text Expanding on the Checklist for Proper Reporting of Evidence in Sport and Exercise Nutrition Trials
  
145
• Intraoperative fluorescence diagnosis in the brain: a systematic review and suggestions for future standards on reporting diagnostic accuracy and clinical utility
  
146
• Checklist for Theoretical Report in Epidemiological Studies (CRT-EE) : explanation and elaboration
  
147
• STAndard Reporting of CAries Detection and Diagnostic Studies (STARCARDDS)
  
148
• Implementing the 27 PRISMA 2020 Statement items for systematic reviews in the sport and exercise medicine, musculoskeletal rehabilitation and sports science fields: the PERSiST (implementing Prisma in Exercise, Rehabilitation, Sport medicine and SporTs science) guidance
  
149
• Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement
  
150
• Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines
  
151
• Extending the CONSORT Statement to moxibustion
  
152
• Consensus-based recommendations for case report in Chinese medicine (CARC)
  
153
• Reporting Guidelines for Whole -Body Vibration Studies in Humans, Animals and Cell Cultures: A Consensus Statement from an International Group of Experts
  
154
• Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extension
  
155
• A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement
  
156
• Social Innovation For Health Research (SIFHR) : Development of the SIFHR Checklist
  
157
• How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines
  
158
• REPORT-PFP : a consensus from the International Patellofemoral Research Network to improve REPORTing of quantitative PatelloFemoral Pain studies
  
159
• Reporting stAndards for research in PedIatric Dentistry (RAPID) : an expert consensus-based statement
  
160
• Improving the reporting quality of reliability generalization meta-analyses: The REGEMA checklist
  
161
• Evaluation of post-introduction COVID- 19 vaccine effectiveness: Summary of interim guidance of the World Health Organization
  
162
• Journal article reporting standards for quantitative research in psychology: The APA Publications and Communications Board task force report
  
163
• Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID- 19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement
  
164
• Describing deprescribing trials better: an elaboration of the CONSORT statement
  
165
• Comprehensive reporting of pelvic floor muscle training for urinary incontinence: CERT-PFMT
  
166
• International Olympic Committee Consensus Statement: Methods for Recording and Reporting of Epidemiological Data on Injury and Illness in Sports 2020 (Including the STROBE Extension for Sports Injury and Illness Surveillance (STROBE-SIIS))
  
167
• RIGHT for Acupuncture: An Extension of the RIGHT Statement for Clinical Practice Guidelines on Acupuncture
  
168
• The APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies
  
169
• Room Indirect Calorimetry Operating and Reporting Standards (RICORS 1.0): A Guide to Conducting and Reporting Human Whole -Room Calorimeter Studies
  
170
• COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures
  
171
• Ensuring best practice in genomics education and evaluation: reporting item standards for education and its evaluation in genomics (RISE 2 Genomics)
  
172
• A Consensus -Based Checklist for Reporting of Survey Studies (CROSS)
  
173
• CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE) : checklist with explanation and elaboration
  
174
• Preferred reporting items for journal and conference abstracts of systematic reviews and meta-analyses of diagnostic test accuracy studies (PRISMA-DTA for Abstracts): checklist, explanation, and elaboration
  
175
• An analysis of preclinical efficacy testing of antivenoms for sub -Saharan Africa: Inadequate independent scrutiny and poor-quality reporting are barriers to improving snakebite treatment and management
  
176
• Artificial intelligence in dental research: Checklist for authors, reviewers, readers
  
177
• EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs)
  
178
• PRIASE 2021 guidelines for reporting animal studies in Endodontology: a consensus-based development
  
179
• The reporting checklist for public versions of guidelines: RIGHT-PVG
  
180
• SQUIRE-EDU (Standards for QUality Improvement Reporting Excellence in Education): Publication Guidelines for Educational Improvement
  
181
• PRISMA-S : an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews
  
182
• Anaesthesia Case Report (ACRE) checklist: a tool to promote high-quality reporting of cases in peri-operative practice
  
183
• Strengthening tRansparent reporting of reseArch on uNfinished nursing CARE : The RANCARE guideline
  
184
• Journal article reporting standards for qualitative primary, qualitative meta-analytic, and mixed methods research in psychology: The APA Publications and Communications Board task force report
  
185
• Defining Group Care Programs: An Index of Reporting Standards
  
186
• Stakeholder analysis in health innovation planning processes: A systematic scoping review
  
187
• PRISMA extension for moxibustion 2020: recommendations, explanation, and elaboration
  
188
• PRISMA (Preferred Reporting Items for Systematic Reviews and Meta -Analyses) Extension for Chinese Herbal Medicines 2020 (PRISMA-CHM 2020)
  
189
• Reporting gaps in immunization costing studies: Recommendations for improving the practice
  
190
• The RIGHT Extension Statement for Traditional Chinese Medicine: Development, Recommendations, and Explanation
  
191
• Proposed Requirements for Cardiovascular Imaging -Related Machine Learning Evaluation (PRIME) : A Checklist: Reviewed by the American College of Cardiology Healthcare Innovation Council
  
192
• Benefit -Risk Assessment of Vaccines. Part II : Proposal Towards Consolidated Standards of Reporting Quantitative Benefit -Risk Models Applied to Vaccines (BRIVAC)
  
193
• BIAS : Transparent reporting of biomedical image analysis challenges
  
194
• Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist
  
195
• STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline
  
196
• TIDieR-Placebo : a guide and checklist for reporting placebo and sham controls
  
197
• Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension
  
198
• Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension
  
199
• The IDEAL Reporting Guidelines: A Delphi Consensus Statement Stage specific recommendations for reporting the evaluation of surgical innovation
  
200
• The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
  
201
• Reporting Guideline for Priority Setting of Health Research (REPRISE)
  
202
• Consensus on the reporting and experimental design of clinical and cognitive-behavioural neurofeedback studies (CRED-nf checklist)
  
203
• PRICE 2020 guidelines for reporting case reports in Endodontics: a consensus-based development
  
204
• PRIRATE 2020 guidelines for reporting randomized trials in Endodontics: a consensus-based development
  
205
• Guidance for reporting intervention development studies in health research (GUIDED) : an evidence-based consensus study
  
206
• Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018)
  
207
• SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist
  
208
• Standards for reporting interventions in clinical trials of cupping (STRICTOC) : extending the CONSORT statement
  
209
• Pa CIR : A tool to enhance pharmacist patient care intervention reporting
  
210
• Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline
  
211
• Guidelines for reporting case studies and series on drug-induced QT interval prolongation and its complications following acute overdose
  
212
• Criteria for describing and evaluating training interventions in healthcare professions – CRe-DEPTH
  
213
• CONSORT extension for reporting N-of- 1 trials for traditional Chinese medicine (CENT for TCM) : Recommendations, explanation and elaboration
  
214
• Reporting items for systematic reviews and meta-analyses of acupuncture: the PRISMA for acupuncture checklist
  
215
• Consolidated criteria for strengthening reporting of health research involving indigenous peoples: the CONSIDER statement
  
216
• Checklist for the preparation and review of pain clinical trial publications: a pain-specific supplement to CONSORT
  
217
• Reporting guidelines on remotely collected electronic mood data in mood disorder (e MOOD)-recommendations
  
218
• CONSORT 2010 statement: extension to randomised crossover trials
  
219
• Reporting of Multi -Arm Parallel -Group Randomized Trials: Extension of the CONSORT 2010 Statement
  
220
• Microbiology Investigation Criteria for Reporting Objectively (MICRO) : a framework for the reporting and interpretation of clinical microbiology data
  
221
• Core Outcome Set -STAndardised Protocol Items: the COS-STAP Statement
  
222
• The Reporting on ERAS Compliance, Outcomes, and Elements Research (RECOvER) Checklist: A Joint Statement by the ERAS ® and ERAS ® USA Societies
  
223
• Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration
  
224
• Improving reporting of Meta -Ethnography : The e MERGe Reporting Guidance
  
225
• The Reporting Items for Patent Landscapes statement
  
226
• Reporting guidelines on how to write a complete and transparent abstract for overviews of systematic reviews of health care interventions
  
227
• The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)
  
228
• PRISMA Extension for Scoping Reviews (PRISMA-ScR) : Checklist and Explanation
  
229
• Systems Perspective of Amazon Mechanical Turk for Organizational Research: Review and Recommendations
  
230
• ESPACOMP Medication Adherence Reporting Guideline (EMERGE)
  
231
• Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension
  
232
• Reporting guidelines for implementation research on nurturing care interventions designed to promote early childhood development
  
233
• Strengthening the reporting of empirical simulation studies: Introducing the STRESS guidelines
  
234
• TIDieR-PHP : a reporting guideline for population health and policy interventions
  
235
• Guidelines for Inclusion of Patient -Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension
  
236
• Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement
  
237
• Structural brain development: A review of methodological approaches and best practices
  
238
• Improving the Development, Monitoring and Reporting of Stroke Rehabilitation Research: Consensus -Based Core Recommendations from the Stroke Recovery and Rehabilitation Roundtable
  
239
• Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements
  
240
• Methodology of assessment and reporting of safety in anti-malarial treatment efficacy studies of uncomplicated falciparum malaria in pregnancy: a systematic literature review
  
241
• Standards for UNiversal reporting of patient Decision Aid Evaluation studies: the development of SUNDAE Checklist
  
242
• Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies -Statement From ATVB Council
  
243
• Guidelines for the Content of Statistical Analysis Plans in Clinical Trials
  
244
• RECORDS : Improved reporting of Monte Carlo Radiation transport studies: Report of the AAPM Research Committee Task Group 268
  
245
• Ten simple rules for neuroimaging meta-analysis
  
246
• CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials
  
247
• Preferred Reporting Items for Overviews of systematic reviews including harms checklist: A pilot tool to be used for balanced reporting of benefits and harms
  
248
• Reporting Guidelines for the Use of Expert Judgement in Model -Based Economic Evaluations
  
249
• Standards for reporting chronic periodontitis prevalence and severity in epidemiologic studies: Proposed standards from the Joint EU / USA Periodontal Epidemiology Working Group
  
250
• Graphics and statistics for cardiology: designing effective tables for presentation and publication
  
251
• Guidelines for reporting meta-epidemiological methodology research
  
252
• Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0
  
253
• Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance
  
254
• Guidelines for Reporting on Latent Trajectory Studies (GRoLTS)
  
255
• AMWA ‒ EMWA ‒ ISMPP Joint Position Statement on the Role of Professional Medical Writers
  
256
• The STROCSS 2024 guideline: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery
  
257
• Unique identification of research resources in the biomedical literature: the Resource Identification Initiative (RRID)
  
258
• Checklist for One Health Epidemiological Reporting of Evidence (COHERE)
  
259
• STARD for Abstracts: essential items for reporting diagnostic accuracy studies in journal or conference abstracts
  
260
• GRIPP 2 reporting checklists: tools to improve reporting of patient and public involvement in research
  
261
• Single organ cutaneous vasculitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data
  
262
• Improving the reporting of clinical trials of infertility treatments (IMPRINT) : modifying the CONSORT statement
  
263
• Improving the reporting of therapeutic exercise interventions in rehabilitation research
  
264
• Guidance to develop individual dose recommendations for patients on chronic hemodialysis
  
265
• A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials and a proposed extension to the CONSORT guidelines
  
266
• AHRQ Series on Complex Intervention Systematic Reviews – Paper 6: PRISMA-CI Extension Statement & Checklist
  
267
• Adaptation of the CARE Guidelines for Therapeutic Massage and Bodywork Publications: Efforts To Improve the Impact of Case Reports
  
268
• A review of published analyses of case-cohort studies and recommendations for future reporting
  
269
• Guidelines for reporting evaluations based on observational methodology
  
270
• Reporting and Guidelines in Propensity Score Analysis: A Systematic Review of Cancer and Cancer Surgical Studies
  
271
• Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO) : Platelet -Rich Plasma and Mesenchymal Stem Cells
  
272
• CONSORT 2010 statement: extension checklist for reporting within person randomised trials
  
273
• CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration
  
274
• Methods and processes of developing the strengthening the reporting of observational studies in epidemiology – veterinary (STROBE-Vet) statement
  
275
• CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
  
276
• STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies
  
277
• SPIRIT 2013 Statement: Defining standard protocol items for clinical trials
  
278
• Best Practices in Data Analysis and Sharing in Neuroimaging using MRI
  
279
• Latent Class Analysis: An example for reporting results
  
280
• Guidelines for Developing and Reporting Machine Learning Predictive Models in Biomedical Research: A Multidisciplinary View
  
281
• Clarity in Reporting Terminology and Definitions of Set End Points in Resistance Training
  
282
• An introduction to using Bayesian linear regression with clinical data
  
283
• Making economic evaluations more helpful for treatment choices in haemophilia
  
284
• Guideline for Reporting Interventions on Spinal Manipulative Therapy: Consensus on Interventions Reporting Criteria List for Spinal Manipulative Therapy (CIRCLe SMT)
  
285
• Guidance on Conducting and REporting DElphi Studies (CREDES) in palliative care: Recommendations based on a methodological systematic review
  
286
• STARD-BLCM : Standards for the Reporting of Diagnostic accuracy studies that use Bayesian Latent Class Models
  
287
• A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement
  
288
• The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines
  
289
• The REFLECT statement: methods and processes of creating reporting guidelines for randomized controlled trials for livestock and food safety by modifying the CONSORT statement
  
290
• Reporting Items for Updated Clinical Guidelines: Checklist for the Reporting of Updated Guidelines (CheckUp)
  
291
• Preferred Reporting Items for the Development of Evidence-based Clinical Practice Guidelines in Traditional Medicine (PRIDE-CPG-TM) : Explanation and elaboration
  
292
• Standards for Reporting Implementation Studies (StaRI) Statement
  
293
• Preferred Reporting Of Case Series in Surgery (PROCESS) 2023 guidelines
  
294
• Consensus on Exercise Reporting Template (CERT) : Modified Delphi Study
  
295
• Development of the Anatomical Quality Assurance (AQUA) Checklist: guidelines for reporting original anatomical studies
  
296
• CONSORT 2010 statement: extension to randomised pilot and feasibility trials
  
297
• Core Outcome Set -STAndards for Reporting: The COS-STAR Statement
  
298
• Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement
  
299
• Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer -Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) and Imaging Group recommendations for radiological examination and reporting with an emphasis on magnetic resonance imaging
  
300
• Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group
  
301
• Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10 -Year Update
  
302
• Irreversible Electroporation (IRE) : Standardization of Terminology and Reporting Criteria for Analysis and Comparison
  
303
• Recommendations for improving the quality of reporting clinical electrochemotherapy studies based on qualitative systematic review
  
304
• METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer
  
305
• Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations -A Report of a European School of Oncology Task Force
  
306
• Transcription factor HIF 1A: downstream targets, associated pathways, polymorphic hypoxia response element (HRE) sites, and initiative for standardization of reporting in scientific literature
  
307
• Eliciting the child’s voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient -Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative
  
308
• CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement
  
309
• REporting recommendations for tumour MARKer prognostic studies (REMARK)
  
310
• Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective
  
311
• Reporting studies on time to diagnosis: proposal of a guideline by an international panel (REST)
  
312
• A Checklist for Reporting Valuation Studies of Multi -Attribute Utility -Based Instruments (CREATE)
  
313
• Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI) : an extension of the STROBE statement for neonatal infection research
  
314
• The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines
  
315
• Development and validation of the guideline for reporting evidence-based practice educational interventions and teaching (GREET)
  
316
• Using theory of change to design and evaluate public health interventions: a systematic review
  
317
• Homeopathic clinical case reports: Development of a supplement (HOM-CASE) to the CARE clinical case reporting guideline
  
318
• Reporting Guidelines for Health Care Simulation Research: Extensions to the CONSORT and STROBE Statements
  
319
• Guidelines for Reporting Articles on Psychiatry and Heart rate variability (GRAPH) : recommendations to advance research communication
  
320
• RAMESES II reporting standards for realist evaluations
  
321
• Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement
  
322
• Medical abortion reporting of efficacy: the MARE guidelines.
  
323
• Strengthening the Reporting of Observational Studies in Epidemiology—Nutritional Epidemiology (STROBE-nut) : An Extension of the STROBE Statement
  
324
• Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use
  
325
• The Single -Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement
  
326
• Consensus on Recording Deep Endometriosis Surgery: the CORDES statement
  
327
• Developing the Clarity and Openness in Reporting: E3-based (CORE) reference user manual for creation of clinical study reports in the era of clinical trial transparency
  
328
• SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee
  
329
• Definition and classification of intraoperative complications (CLASSIC) : Delphi study and pilot evaluation
  
330
• Improving research practice in rat orthotopic and partial orthotopic liver transplantation: a review, recommendation, and publication guide
  
331
• Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review
  
332
• Standardized outcomes reporting in metabolic and bariatric surgery
  
333
• Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting
  
334
• DELTA 2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial
  
335
• Transparent reporting of data quality in distributed data networks
  
336
• Quality of methods reporting in animal models of colitis
  
337
• Guidelines for reporting of health interventions using mobile phones: mobile health (mHealth) evidence reporting and assessment (m ERA) checklist
  
338
• Quality of pain intensity assessment reporting: ACTTION systematic review and recommendations
  
339
• An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver -FibroSTARD standards
  
340
• STROBE-AMS : recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship
  
341
• Reporting guidelines for population pharmacokinetic analyses
  
342
• Recommendations for the improved effectiveness and reporting of telemedicine programs in developing countries: results of a systematic literature review
  
343
• Guidelines for the reporting of treatment trials for alcohol use disorders
  
344
• Development of the Standards of Reporting of Neurological Disorders (STROND) checklist: A guideline for the reporting of incidence and prevalence studies in neuroepidemiology
  
345
• A review of 40 years of enteric antimicrobial resistance research in Eastern Africa: what can be done better?
  
346
• Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT
  
347
• RiGoR: reporting guidelines to address common sources of bias in risk model development
  
348
• Reporting standards for guideline-based performance measures
  
349
• Utstein-style guidelines on uniform reporting of in-hospital cardiopulmonary resuscitation in dogs and cats
  
350
• Guidelines for reporting embedded recruitment trials
  
351
• PRISMA harms checklist: improving harms reporting in systematic reviews
  
352
• Developing a methodological framework for organisational case studies: a rapid review and consensus development process
  
353
• The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
  
354
• The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies
  
355
• A checklist to improve reporting of group-based behaviour-change interventions
  
356
• The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
  
357
• Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement
  
358
• A call for transparent reporting to optimize the predictive value of preclinical research
  
359
• Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders
  
360
• The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
  
361
• Setting number of decimal places for reporting risk ratios: rule of four
  
362
• Too many digits: the presentation of numerical data
  
363
• The CONSORT Statement: Application within and adaptations for orthodontic trials
  
364
• A structured approach to documenting a search strategy for publication: a 12 step guideline for authors
  
365
• Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group
  
366
• Standardized reporting guidelines for emergency department syncope risk-stratification research
  
367
• Designing and reporting case series in plastic surgery
  
368
• Disaster medicine reporting: the need for new guidelines and the CONFIDE statement
  
369
• Development and validation of reporting guidelines for studies involving data linkage
  
370
• A reporting guide for studies on individual differences in traffic safety
  
371
• Translating trial-based molecular monitoring into clinical practice: importance of international standards and practical considerations for community practitioners
  
372
• Canadian Association of Gastroenterology consensus guidelines on safety and quality indicators in endoscopy
  
373
• A tool to analyze the transferability of health promotion interventions
  
374
• A new manner of reporting pressure results after glaucoma surgery
  
375
• Do the media provide transparent health information? A cross-cultural comparison of public information about the HPV vaccine
  
376
• Recommendations for the reporting of foot and ankle models
  
377
• An introduction to standardized clinical nomenclature for dysmorphic features: the Elements of Morphology project
  
378
• Strengthening the Reporting of Observational Studies in Epidemiology for Respondent -Driven Sampling Studies: ‘ STROBE-RDS ’ Statement.
  
379
• CONSORT extension for reporting N-of- 1 trials (CENT) 2015 Statement
  
380
• A protocol format for the preparation, registration and publication of systematic reviews of animal intervention studies
  
381
• Reporting standards for literature searches and report inclusion criteria: making research syntheses more transparent and easy to replicate
  
382
• Preferred Reporting Items for Systematic Review and Meta -Analyses of individual participant data: the PRISMA-IPD Statement
  
383
• Evaluating complex interventions in end of life care: the MORECare statement on good practice generated by a synthesis of transparent expert consultations and systematic reviews
  
384
• Biospecimen reporting for improved study quality (BRISQ)
  
385
• Developing a guideline to standardize the citation of bioresources in journal articles (CoBRA)
  
386
• Reporting Guidelines for Clinical Pharmacokinetic Studies: The Clin PK Statement
  
387
• Using the spinal cord injury common data elements
  
388
• Guidelines for assessment of bone microstructure in rodents using micro-computed tomography
  
389
• Instrumental variable methods in comparative safety and effectiveness research
  
390
• Protecting the power of interventions through proper reporting
  
391
• Reporting of data from out-of-hospital cardiac arrest has to involve emergency medical dispatching – taking the recommendations on reporting OHCA the Utstein style a step further
  
392
• A position paper on standardizing the nonneoplastic kidney biopsy report
  
393
• Using qualitative methods for attribute development for discrete choice experiments: issues and recommendations
  
394
• Reporting of interaction
  
395
• Head, neck, and brain tumor embolization guidelines
  
396
• Reporting outcomes of back pain trials: a modified Delphi study
  
397
• A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints
  
398
• Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data
  
399
• Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data
  
400
• Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data
  
401
• Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study
  
402
• Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet
  
403
• A new standardized format for reporting hearing outcome in clinical trials
  
404
• A consensus approach toward the standardization of back pain definitions for use in prevalence studies
  
405
• A proposed taxonomy of terms to guide the clinical trial recruitment process
  
406
• Minimum data elements for research reports on CFS
  
407
• Reporting standards for angiographic evaluation and endovascular treatment of cerebral arteriovenous malformations
  
408
• How to report low-level laser therapy (LLLT) /photomedicine dose and beam parameters in clinical and laboratory studies
  
409
• Common data elements for posttraumatic stress disorder research
  
410
• American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants
  
411
• Completeness of reporting of radiation therapy planning, dose, and delivery in veterinary radiation oncology manuscripts from 2005 to 2010
  
412
• Criteria for Reporting the Development and Evaluation of Complex Interventions in healthcare: revised guideline (CReDECI 2)
  
413
• TRIPOD + AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
  
414
• Preferred Reporting Items for Systematic Review and Meta -Analysis Protocols (PRISMA-P) 2015 statement
  
415
• Reporting guidance for violence risk assessment predictive validity studies: the RAGEE Statement
  
416
• Standards for reporting qualitative research: a synthesis of recommendations
  
417
• A systematic review of systematic reviews and meta-analyses of animal experiments with guidelines for reporting
  
418
• Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically
  
419
• Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology
  
420
• Reporting standards for studies of diagnostic test accuracy in dementia: The STARDdem Initiative.
  
421
• Strengthening the reporting of molecular epidemiology for infectious diseases (STROME-ID) : an extension of the STROBE statement
  
422
• Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
  
423
• Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries
  
424
• CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials
  
425
• The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline Development
  
426
• Documenting Clinical and Laboratory Images in Publications: The CLIP Principles
  
427
• ICMJE : Uniform Format for Disclosure of Competing Interests in ICMJE Journals
  
428
• Selection and presentation of imaging figures in the medical literature
  
429
• Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
  
430
• Finding What Works in Health Care: Standards for Systematic Reviews. Chapter 5 – Standards for Reporting Systematic Reviews
  
431
• Systematic Reviews. CRD ’s guidance for undertaking reviews in health care
  
432
• The Hu GENet ™ Hu GE Review Handbook, version 1.0. Guidelines for systematic review and meta-analysis of gene disease association studies
  
433
• Cochrane Handbook for Systematic Reviews of Interventions Version 6.1
  
434
• Writing for Publication in Veterinary Medicine. A Practical Guide for Researchers and Clinicians
  
435
• Publication of population data for forensic purposes
  
436
• Publication of population data of linearly inherited DNA markers in the International Journal of Legal Medicine
  
437
• Proposed definitions and criteria for reporting time frame, outcome, and complications for clinical orthopedic studies in veterinary medicine
  
438
• Recommended guidelines for the conduct and evaluation of prognostic studies in veterinary oncology
  
439
• Update of the stroke therapy academic industry roundtable preclinical recommendations
  
440
• Good laboratory practice: preventing introduction of bias at the bench
  
441
• Consensus-based reporting standards for diagnostic test accuracy studies for paratuberculosis in ruminants
  
442
• A gold standard publication checklist to improve the quality of animal studies, to fully integrate the Three Rs, and to make systematic reviews more feasible
  
443
• The ARRIVE Guidelines 2.0: updated guidelines for reporting animal research
  
444
• International Society for Medical Publication Professionals Code of Ethics
  
445
• Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials
  
446
• What should be done to tackle ghostwriting in the medical literature?
  
447
• Electrodermal activity at acupoints: literature review and recommendations for reporting clinical trials
  
448
• Systematic review to determine best practice reporting guidelines for AFO interventions in studies involving children with cerebral palsy
  
449
• EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting
  
450
• ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis
  
451
• International Spinal Cord Injury Core Data Set (version 3.0) – including standardization of reporting
  
452
• Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting
  
453
• The importance of uniform venous terminology in reports on varicose veins
  
454
• Recommendations for reporting perioperative transoesophageal echo studies
  
455
• Guidelines for reporting an f MRI study
  
456
• Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations
  
457
• Criteria for evaluation of novel markers of cardiovascular risk
  
458
• American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation
  
459
• Research reporting standards for radioembolization of hepatic malignancies
  
460
• Research reporting standards for image-guided ablation of bone and soft tissue tumors
  
461
• EANM procedure guidelines for brain neurotransmission SPECT using I-labelled dopamine transporter ligands, version 2
  
462
• Transcatheter Therapy for Hepatic Malignancy: Standardization of Terminology and Reporting Criteria
  
463
• Reporting standards for percutaneous thermal ablation of renal cell carcinoma
  
464
• Research reporting standards for percutaneous vertebral augmentation
  
465
• Reporting standards for percutaneous interventions in dialysis access
  
466
• Reporting standards for clinical evaluation of new peripheral arterial revascularization devices
  
467
• Guidelines for the reporting of renal artery revascularization in clinical trials
  
468
• Reporting standards for carotid interventions from the Society for Vascular Surgery
  
469
• Reporting standards for carotid artery angioplasty and stent placement
  
470
• Standardized definitions and clinical endpoints in carotid artery and supra-aortic trunk revascularization trials
  
471
• Setting the standards for reporting ruptured abdominal aortic aneurysm
  
472
• Endovascular repair compared with operative repair of traumatic rupture of the thoracic aorta: a nonsystematic review and a plea for trauma-specific reporting guidelines
  
473
• Reporting standards for thoracic endovascular aortic repair (TEVAR)
  
474
• Research reporting standards for endovascular treatment of pelvic venous insufficiency
  
475
• Reporting standards for endovascular treatment of pulmonary embolism
  
476
• Reporting Standards for Endovascular Repair of Saccular Intracranial Cerebral Aneurysms
  
477
• Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke
  
478
• Target registration and target positioning errors in computer-assisted neurosurgery: proposal for a standardized reporting of error assessment
  
479
• Recommended guidelines for reporting on emergency medical dispatch when conducting research in emergency medicine: the Utstein style
  
480
• Recommended guidelines for reviewing, reporting, and conducting research on post-resuscitation care: the Utstein style
  
481
• Utstein-style guidelines for uniform reporting of laboratory CPR research
  
482
• Recommendations for uniform reporting of data following major trauma–the Utstein style
  
483
• Recommended guidelines for reviewing, reporting, and conducting research on in-hospital resuscitation: the in-hospital ‘Utstein style’
  
484
• Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop
  
485
• EACTS / ESCVS best practice guidelines for reporting treatment results in the thoracic aorta
  
486
• Consensus statement: Defining minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass
  
487
• Guidelines for reporting data and outcomes for the surgical treatment of atrial fibrillation
  
488
• Recommendations for reporting morbid events after heart valve surgery
  
489
• Standards for reporting results of refractive surgery
  
490
• Quality of study methods in individual- and group-level HIV intervention research: critical reporting elements
  
491
• Quality of reporting in evaluations of surgical treatment of trigeminal neuralgia: recommendations for future reports
  
492
• Guidelines for reporting case series of tumours of the colon and rectum
  
493
• Guidance on reporting ultrasound exposure conditions for bio-effects studies
  
494
• American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS)
  
495
• Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group
  
496
• Standardized reporting guidelines for studies evaluating risk stratification of ED patients with potential acute coronary syndromes
  
497
• Calibration methods used in cancer simulation models and suggested reporting guidelines
  
498
• Preschool vision screening: what should we be detecting and how should we report it? Uniform guidelines for reporting results of preschool vision screening studies
  
499
• The lessons of QUANTEC : recommendations for reporting and gathering data on dose-volume dependencies of treatment outcome
  
500
• A reporting guideline for clinical platelet transfusion studies from the BEST Collaborative
  
501
• Clinical trials focusing on cancer pain educational interventions: core components to include during planning and reporting
  
502
• Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR / ACR collaborative recommendations
  
503
• Exercise therapy and low back pain: insights and proposals to improve the design, conduct, and reporting of clinical trials
  
504
• Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate -Specific Antigen Working Group
  
505
• Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis
  
506
• Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
  
507
• Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
  
508
• Methodological challenges when using actigraphy in research
  
509
• Draft STROBE checklist for conference abstracts
  
510
• Conflict of Interest in Peer -Reviewed Medical Journals
  
511
• Financial Conflicts of Interest Checklist 2010 for clinical research studies
  
512
• Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest
  
513
• How to formulate research recommendations
  
514
• Suggestions for improving the reporting of clinical research: the role of narrative
  
515
• The case for structuring the discussion of scientific papers
  
516
• More medical journals should inform their contributors about three key principles of graph construction
  
517
• Figures in clinical trial reports: current practice & scope for improvement
  
518
• Recommendations for the assessment and reporting of multivariable logistic regression in transplantation literature
  
519
• Reporting results of latent growth modeling and multilevel modeling analyses: some recommendations for rehabilitation psychology
  
520
• Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls
  
521
• Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
  
522
• Statistics in medicine–reporting of subgroup analyses in clinical trials
  
523
• Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study
  
524
• Bayesian methods in health technology assessment: a review
  
525
• Basic Statistical Reporting for Articles Published in Biomedical Journals: The “Statistical Analyses and Methods in the Published Literature” or The SAMPL Guidelines
  
526
• Establishing a knowledge trail from molecular experiments to clinical trials
  
527
• Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers
  
528
• Best practices in the reporting of participatory action research: Embracing both the forest and the trees
  
529
• A comprehensive checklist for reporting the use of OSCEs
  
530
• Quality of standardised patient research reports in the medical education literature: review and recommendations
  
531
• Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data
  
532
• Perspective: Guidelines for reporting team-based learning activities in the medical and health sciences education literature
  
533
• Authors’ Submission Toolkit: a practical guide to getting your research published
  
534
• Good publication practice for communicating company sponsored medical research: GPP 3
  
535
• Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization
  
536
• A new structure for quality improvement reports
  
537
• Guidelines for conducting and reporting economic evaluation of fall prevention strategies
  
538
• Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics
  
539
• Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting
  
540
• Reporting format for economic evaluation. Part II : Focus on modelling studies
  
541
• Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies
  
542
• Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report
  
543
• Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost -Effectiveness in Health and Medicine
  
544
• The quality of mixed methods studies in health services research
  
545
• Qualitative research review guidelines – RATS
  
546
• Evolving guidelines for publication of qualitative research studies in psychology and related fields
  
547
• Revealing the wood and the trees: reporting qualitative research
  
548
• Qualitative research: standards, challenges, and guidelines
  
549
• RAMESES publication standards: meta-narrative reviews
  
550
• RAMESES publication standards: realist syntheses
  
551
• Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group
  
552
• Meta-analysis of individual participant data: rationale, conduct, and reporting
  
553
• PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity
  
554
• PRISMA 2020 for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts
  
555
• The STARD statement for reporting diagnostic accuracy studies: application to the history and physical examination
  
556
• Capturing momentary, self-report data: a proposal for reporting guidelines
  
557
• Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES)
  
558
• Guidelines for field surveys of the quality of medicines: a proposal
  
559
• A guide for the design and conduct of self-administered surveys of clinicians
  
560
• Good practice in the conduct and reporting of survey research
  
561
• Reporting genetic results in research studies: summary and recommendations of an NHLBI working group
  
562
• Recommendations for biomarker identification and qualification in clinical proteomics
  
563
• Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines
  
564
• Gene expression-based prognostic signatures in lung cancer: ready for clinical use?
  
565
• Anecdotes as evidence
  
566
• Recommendations for reporting adverse drug reactions and adverse events of traditional Chinese medicine
  
567
• Guidelines for submitting adverse event reports for publication
  
568
• Guidelines for clinical case reports in behavioral clinical psychology
  
569
• Instructions to authors for case reporting are limited: a review of a core journal list
  
570
• Reporting participation in case-control studies
  
571
• Conducting and reporting case series and audits–author guidelines for acupuncture in medicine
  
572
• Appropriate use and reporting of uncontrolled case series in the medical literature
  
573
• Improving the reporting of clinical case series
  
574
• EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology
  
575
• Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology
  
576
• A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement
  
577
• STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME) : An extension of the STROBE statement
  
578
• STrengthening the REporting of Genetic Association Studies (STREGA) : An Extension of the STROBE Statement.
  
579
• Guidelines for conducting and reporting mixed research in the field of counseling and beyond
  
580
• Reporting experiments in homeopathic basic research (REHBaR) – a detailed guideline for authors
  
581
• Guidelines for the design, conduct and reporting of human intervention studies to evaluate the health benefits of foods
  
582
• Good research practices for comparative effectiveness research: Defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources
  
583
• Guidelines for reporting non-randomised studies
  
584
• Setting the bar in phase II trials: the use of historical data for determining “go/no go” decision for definitive phase III testing
  
585
• GNOSIS : Guidelines for Neuro -Oncology : Standards for Investigational Studies – reporting of surgically based therapeutic clinical trials
  
586
• The standard of reporting of health-related quality of life in clinical cancer trials
  
587
• A systematic review of the reporting of Data Monitoring Committees’ roles, interim analysis and early termination in pediatric clinical trials
  
588
• “Brimful of STARLITE ”: toward standards for reporting literature searches
  
589
• Systematic prioritization of the STARE-HI reporting items. An application to short conference papers on health informatics evaluation
  
590
• CONSORT-EHEALTH : improving and standardizing evaluation reports of Web-based and mobile health interventions
  
591
• Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension
  
592
• Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
  
593
• Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ
  
594
• Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal
  
595
• Relevance of CONSORT reporting criteria for research on eHealth interventions
  
596
• Reporting guidelines for music-based interventions
  
597
• Reporting whole-body vibration intervention studies: recommendations of the International Society of Musculoskeletal and Neuronal Interactions
  
598
• Reporting standards for studies of tailored interventions
  
599
• Reporting data on homeopathic treatments (RedHot) : A supplement to CONSORT
  
600
• Evaluating the quality of reporting occupational therapy randomized controlled trials by expanding the CONSORT criteria
  
601
• WIDER recommendations for reporting of behaviour change interventions
  
602
• Evidence-based behavioral medicine: what is it and how do we achieve it?
  
603
• CONSORT 2010: CONSORT-C (children)
  
604
• The CONSORT statement checklist in allergen-specific immunotherapy: a GA 2 LEN paper
  
605
• Improving the reporting of pragmatic trials: an extension of the CONSORT statement
  
606
• CONSORT for reporting randomised trials in journal and conference abstracts
  
607
• CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts
  
608
• Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT Statement
  
609
• Consort 2010 statement: extension to cluster randomised trials
  
610
• Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement
  
611
• Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA) : extending the CONSORT statement
  
612
• STARE-HI – Statement on reporting of evaluation studies in Health Informatics
  
613
• The ORION statement: guidelines for transparent reporting of Outbreak Reports and Intervention studies Of Nosocomial infection
  
614
• Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
  
615
• Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting
  
616
• Reporting and presenting information retrieval processes: the need for optimizing common practice in health technology assessment
  
617
• Guidelines for reporting reliability and agreement studies (GRRAS) were proposed
  
618
• SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process
  
619
• Refining a checklist for reporting patient populations and service characteristics in hospice and palliative care research
  
620
• Point and interval estimates of effect sizes for the case-controls design in neuropsychology: rationale, methods, implementations, and proposed reporting standards
  
621
• Recommended guidelines for uniform reporting of pediatric advanced life support: the pediatric Utstein style
  
622
• Consolidated criteria for reporting qualitative research (COREQ) : a 32-item checklist for interviews and focus groups
  
623
• Guidelines for reporting results of quality of life assessments in clinical trials
  
624
• Recommendations for reporting economic evaluations of haemophilia prophylaxis
  
625
• Overview of methods used in cross-cultural comparisons of menopausal symptoms and their determinants: Guidelines for Strengthening the Reporting of Menopause and Aging (STROMA) studies
  
626
• Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement
  
627
• GNOSIS : guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials
  
628
• Standard guidelines for publication of deep brain stimulation studies in Parkinson’s disease (Guide 4 DBS-PD)